Nevro (NVRO) Earnings Date, Estimates & Call Transcripts → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free NVRO Stock Alerts $10.16 -1.37 (-11.88%) (As of 04:10 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 6EstimatedActual EPS (May. 7) -$0.70 Beat By $0.32 Consensus EPS (May. 7) -$1.02 Listen to Call Get Nevro Earnings AlertsEnter your email address below to receive the latest news and earnings results for NVRO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNVRO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVRO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read Nevro Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($1.10)($0.86)($0.95) Q2 20243($0.67)($0.53)($0.59) Q3 20243($0.70)($0.39)($0.57) Q4 20243($0.42)($0.19)($0.34) FY 202412($2.89)($1.97)($2.45) Q1 20251($0.91)($0.91)($0.91) Q2 20251($0.60)($0.60)($0.60) Q3 20251($0.63)($0.63)($0.63) NVRO Earnings Date and InformationNevro last issued its quarterly earnings results on May 7th, 2024. The medical equipment provider reported ($0.70) EPS for the quarter, beating analysts' consensus estimates of ($1.02) by $0.32. The firm earned $101.90 million during the quarter, compared to analysts' expectations of $97.90 million. Its quarterly revenue was up 5.8% compared to the same quarter last year. Nevro has generated ($2.57) earnings per share over the last year (($2.57) diluted earnings per share). Earnings for Nevro are expected to grow in the coming year, from ($2.54) to ($2.23) per share. Nevro has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off prior year's report dates.Read More Nevro Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/6/2024Estimated)------- 5/7/2024Q1 2024($1.02)($0.70)+$0.32($0.70)$97.90 million$101.90 million 2/21/2024Q4 2023($0.50)($0.15)+$0.35($0.05)$115.93 million$116.18 million11/1/2023Q3 2023($0.77)($0.65)+$0.12($0.65)$95.87 million$103.86 million 8/1/2023Q2 2023($0.68)($0.69)($0.01)($0.69)$108.19 million$108.80 million 4/26/2023Q1 2023($1.06)($0.98)+$0.08($0.98)$95.35 million$96.33 million 2/16/2023Q4 2022($0.49)($0.54)($0.05)($0.54)$113.70 million$113.84 million Get the Latest News and Ratings for NVRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nevro and its competitors with MarketBeat's FREE daily newsletter. 11/2/2022Q3 2022($0.71)($0.62)+$0.09($3.46)$99.08 million$100.47 million 8/3/2022Q2 2022($0.81)($0.71)+$0.10($0.71)$104.66 million$104.21 million5/4/2022Q1 2022($1.11)($0.98)+$0.13($0.98)$86.19 million$87.40 million 2/23/2022Q4 2021($0.86)($0.86)-($0.86)$100.70 million$102.80 million 11/7/2021Q3 2021($0.87)($0.86)+$0.01($0.30)$91.59 million$93.21 million 8/4/2021Q2 2021($0.71)($0.62)+$0.09($0.62)$102.83 million$102.30 million Nevro Earnings - Frequently Asked Questions When is Nevro's earnings date? Nevro has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates. Learn more on NVRO's earnings history. Did Nevro beat their earnings estimates last quarter? In the previous quarter, Nevro (NYSE:NVRO) reported ($0.70) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.02) by $0.32. Learn more on analysts' earnings estimate vs. NVRO's actual earnings. How can I listen to Nevro's earnings conference call? The conference call for Nevro's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Nevro generate each year? Nevro (NYSE:NVRO) has a recorded annual revenue of $425.17 million. How much profit does Nevro generate each year? Nevro (NYSE:NVRO) has a recorded net income of -$92.21 million. NVRO has generated -$2.57 earnings per share over the last four quarters. What is Nevro's EPS forecast for next year? Nevro's earnings are expected to grow from ($2.54) per share to ($2.23) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ANIK Earnings Date SKIN Earnings Date NPCE Earnings Date OSUR Earnings Date PLSE Earnings Date SRDX Earnings Date CVRX Earnings Date TCMD Earnings Date GUTS Earnings Date BVS Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NYSE:NVRO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nevro Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.